Patents Assigned to Roche Sequencing Solutions, Inc.
-
Publication number: 20260234714Abstract: This disclosure provides a biochip comprising a plurality of wells. The biochip includes a membrane that is disposed in or adjacent to an individual well of the plurality of wells. The membrane comprises a nanopore, and the individual well comprises an electrode that detects a signal upon ionic flow through the pore in response to a species passing through or adjacent to the nanopore. The electrode can be a non-sacrificial electrode. A lipid bilayer can be formed over the plurality of wells using a bubble.Type: ApplicationFiled: April 17, 2025Publication date: August 13, 2026Applicant: Roche Sequencing Solutions, Inc.Inventors: Randall W. Davis, Edward Shian Liu, Eric Takeshi Harada, Anne Aguirre, Andrew Trans, James Pollard, Cynthia Cech
-
Patent number: 12698523Abstract: The invention relates to compounds, methods and compositions for improving on nucleic acid polymerization, including DNA replication by in vitro primer extension to generate, for example, polymers for nanopore-based single molecule sequencing of a DNA template. A nucleic acid polymerase reaction composition is provided with polymerization enhancement moieties, which allows enhanced DNA polymerase activity with nucleotide analogs, resulting in improved length of primer extension products for sequencing applications.Type: GrantFiled: December 21, 2021Date of Patent: August 4, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Jagadeeswaran Chandrasekar, Drew Goodman, Aaron Jacobs, Mark Stamatios Kokoris, Lacey Merrill, Melud Nabavi, Dylan O'Connell, John Tabone
-
Publication number: 20260218289Abstract: Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from V149K, E287R, H35G, T109K, P151K, K147N, E111N, M113A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. The ?-hemolysin variants may also include a substitution at H144A and/or a series of glycine residues spanning residues 127 to 131 of the mature, wild-type alpha hemolysin. Also provided are nanopore assemblies including the alpha-hemolysin variants, the assembly having a decreased time-to-thread. The decreased time-to-thread, for example, increases DNA sequencing efficiency and accuracy.Type: ApplicationFiled: July 3, 2025Publication date: July 30, 2026Applicant: Roche Sequencing Solutions, Inc.Inventors: Timothy K. CRAIG, Mark R. AMBROSO, Corissa J. HARRIS, Matthew M. DIPIETRO, Yaozhong ZOU, Marshall W. PORTER
-
Patent number: 12693263Abstract: A nanopore based sequencing system includes a plurality of nanopore sensors. Each nanopore sensor has a portion for receiving a fluid. The nanopore based sequencing system includes a fluid chamber configured to guide the fluid over the plurality of nanopore sensors and an inlet configured to deliver the fluid into the fluid chamber. At least a portion of the fluid chamber is made of a material that has been molded around at least a portion of an electrode.Type: GrantFiled: October 21, 2025Date of Patent: July 28, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Edward Liu, Kenneth M. Stothers, Markus Wallgren, Janusz B. Wojtowicz, Robert A. Yuan
-
Publication number: 20260209281Abstract: Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from 0K, A1K, A1R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E111N, 127-131G, D128K, K147N, V149K, E287R, M298A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. Also provided are compositions including the variants of alpha-hemolysin, nanopore assemblies including the alpha-hemolysin variants, and methods of sequencing nucleic acids incorporating the same.Type: ApplicationFiled: June 18, 2025Publication date: July 23, 2026Applicant: Roche Sequencing Solutions, Inc.Inventor: Timothy K. Craig
-
Publication number: 20260146283Abstract: Provided are DNA library preparation methods and compositions that duplicate a target nucleic acid sequence. A target DNA template including the target sequence is circularized via an end adapter to form a circular construct, which is bidirectionally extended by a polymerase-mediated extension that is initiated at nick sites of the end adapter. Following polymerase-mediated extension, a double-length DNA template is formed that includes two copies of the target DNA template (and hence two copies of the target sequence). Each strand of the double-length DNA template includes a parental polynucleotide strand joined to a newly synthesized daughter strand copy of the parental polynucleotide strand. Predetermined sequences can be included in the double-length DNA template, such a primer sequences, unique molecule identifiers, and sequence indexes. Sequencing of the double-length DNA template can reveal genetic/epigenetic information associated with the target sequence.Type: ApplicationFiled: September 25, 2025Publication date: May 28, 2026Applicant: Roche Sequencing Solutions, Inc.Inventors: Jagadeeswaran Chandrasekar, Joseph Welborn Horsman, Mark Stamatios Kokoris, Robert N. McRuer, John C. Tabone
-
Patent number: 12624393Abstract: In one aspect of the present disclosure is a targeted sequencing workflow where an input sample comprising a sufficient quantity of genomic material is provided such minimal or no amplification cycles are utilized prior to sequencing.Type: GrantFiled: April 6, 2023Date of Patent: May 12, 2026Assignees: Roche Sequencing Solutions, Inc., Ventana Medical Systems, Inc.Inventors: Nelson R Alexander, Daniel Burgess, Heidi J Rosenbaum, Stacey Stanislaw
-
Patent number: 12618826Abstract: A nanopore-based sequencing system includes a plurality of nanopore-based sequencing chips. Each of the nanopore-based sequencing chips comprises a plurality of nanopore sensors. The system comprises at least one flow cell coupled to at least one of the plurality of nanopore-based sequencing chips, wherein the flow cell coupled to the at least one of the plurality of nanopore-based sequencing chips comprises one or more fluidic flow channels that allow a fluid external to the system to flow on top of the nanopore-based sequencing chip and out of the system. The system further comprises a printed circuit board electrically connected to the plurality of nanopore-based sequencing chips.Type: GrantFiled: March 12, 2024Date of Patent: May 5, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Yuri Mitnick, Xu Ouyang, Janusz B. Wojtowicz
-
Patent number: 12596098Abstract: Epitachophoresis (ETP) methods and devices that improve concentrating samples and/or separating components of samples. ETP methods and devices allow for electromigration in two dimensions. Electromigration of a sample may first occur in a first dimension along a single plane. Electromigration may then continue in a second dimension, which may be different from the first dimension. The volume where the electromigration occurs may significantly reduce from the first dimension to the second dimension. This smaller dimension may allow for increased concentration of samples or improved separation of components of a sample.Type: GrantFiled: April 20, 2022Date of Patent: April 7, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Frantisek Foret, Ivona Voracova, Jan Prikryl, Jakub Novotny
-
Patent number: 12595591Abstract: The present technology provides an approach to designing libraries of peptide sequences for discovery and testing of significantly more motifs than would be otherwise available in a given fixed library format. The technology includes a plurality of x-mers embedded in N-mer peptides sequences, where N and x are integers and where N is greater than x. This approach provides for the representation of multiple unique x-mer peptides in a single N-mer peptide feature.Type: GrantFiled: June 26, 2020Date of Patent: April 7, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Lauren Goodrich, Victor Lyamichev, Jigar Patel, Richard Pinapati, Eric Sullivan, Todd Richmond
-
Patent number: 12590328Abstract: The present disclosure is directed to compositions, kits, and methods of target enrichment by unidirectional primer extension, whereby the compositions, kits, and methods utilize both poison primers and target capture primers.Type: GrantFiled: July 7, 2021Date of Patent: March 31, 2026Assignees: ROCHE SEQUENCING SOLUTIONS, INC., KAPA BIOSYSTEMS, INC.Inventors: Richard Dannebaum, Brian Christopher Godwin, David L. Penkler, Etienne Slabbert, Ruben van der Merwe
-
Patent number: 12571050Abstract: The invention is a method of predicting response to therapy in a cancer patient by serial sampling the patient's cell-free tumor nucleic acids to determine a change in the number of mutations per amount of plasma.Type: GrantFiled: February 11, 2019Date of Patent: March 10, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Aarthi Balasubramanyam, Christine Ju, Xiaoju Ma, Thomas Muley, Felix Herth, Nalin Tikoo, Birgit Wehnl, Liu Xi, Stephanie J. Yaung
-
Patent number: 12571032Abstract: The present disclosure provides methods and compositions for enhancing the processivity of a polymerase in catalyzing template-dependent DNA synthesis in high concentrations of salt. Also disclosed are methods and compositions for enhancing the assembly of polymerase-template complex compatible with active DNA synthesis in the presence of low levels of nucleotides and at a high temperature, such as temperatures at or near the melting temperature of the polymerase.Type: GrantFiled: May 6, 2021Date of Patent: March 10, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Aruna Ayer, Preethi Sarvabhowman, Charles Schwab
-
Patent number: 12571059Abstract: Methods for the rapid detection of the presence or absence of Epstein Barr Virus (EBV) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting EBV, and kits are provided that are designed for the detection of target regions of EBV. Also described are kits, reaction mixtures, and oligonucleotides (e.g., primer and probe) for the amplification and detection of EBV. Also described are primers and probes that detect different regions of EBV, and can be employed in a dual target assay for simultaneously detecting two different and non-overlapping target regions of EBV.Type: GrantFiled: July 24, 2020Date of Patent: March 10, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Aaron T. Hamilton, Marintha Heil, Debra Liggett, Jingtao Sun, Ling Wang, Xiaoning Wu
-
Patent number: 12566153Abstract: A nanopore based sequencing chip package is disclosed. The nanopore based sequencing chip package includes a reservoir defined by a plurality of surfaces. The chip package includes a nanopore cell array comprising a plurality of nanopore sensor cells enclosed by the reservoir. Each nanopore sensor cell has a working electrode. At least one surface of the reservoir is configured to be in contact with a conducting fluid when the conducting fluid is flowing through the reservoir. The chip package further includes a counter electrode disposed on the at least one surface of the reservoir.Type: GrantFiled: June 2, 2022Date of Patent: March 3, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: J. William Maney, Jr., David Bruce Robinson, Markus Wallgren, Robert A. Yuan
-
Publication number: 20260056183Abstract: A method of forming a plurality of lipid bilayers over an array of cells in a nanopore based sequencing chip is disclosed. Each of the cells comprises a well. A first salt buffer solution with a first osmolarity is flowed over a cell in the nanopore based sequencing chip to substantially fill a well in the cell with the first salt buffer solution. A lipid and solvent mixture is flowed over the cell to deposit a lipid membrane over the well that encloses the first salt buffer solution in the well. A second salt buffer solution with a second osmolarity is flowed above the well to reduce the thickness of the lipid membrane, wherein the second osmolarity is a lower osmolarity than the first osmolarity such that an osmotic imbalance is created between a first volume inside the well and a second volume outside the well.Type: ApplicationFiled: June 27, 2025Publication date: February 26, 2026Applicant: Roche Sequencing Solutions, Inc.Inventors: Geoffrey Barrall, Licheng Niu, Pirooz Parvarandeh
-
Patent number: 12562238Abstract: Techniques described herein relate to systems and methods for parallel DNA molecules sequencing. A preprocessor can receive raw data frames from a sensor chip including 100,000 or more cells, where each raw data frame can include detection signals from the 100,000 or more cells at a given time during the formation of the 100,000 or more cells or during the DNA molecules sequencing using the 100,000 or more cells. The preprocessor can then extract relevant information for determining states of the cells from the raw data frames, generate one or more digested frames that includes the extracted information, and send the digested frames to a processor for processing, such as base determination. Because the number of digested frames sent to the processor is less than a number of the raw data frames and the digested frames include preprocessed data, the amount of data being transferred to the processor and the amount of data processing by the processor can be reduced.Type: GrantFiled: September 15, 2021Date of Patent: February 24, 2026Assignee: Roche Sequencing Solutions, Inc.Inventor: Santiago Fernandez-Gomez
-
Patent number: 12529100Abstract: Sequencing adaptors and methods are provided for preparation of polynucleotides for sequencing. The sequencing adaptors contain a portion of a recognition sequence for a methyl-dependent endonuclease. Unwanted adaptor dimers that form during ligation of adaptors to target polynucleotides produce a complete restriction sequence and are cleaved by the endonuclease, followed by exonuclease digestion, thereby removing the dimers.Type: GrantFiled: October 26, 2022Date of Patent: January 20, 2026Assignee: Roche Sequencing Solutions, Inc.Inventors: Arkadiusz Bibillo, Randall W. Davis
-
Publication number: 20260009070Abstract: Methods and systems for constructing cfDNA sequence libraries, including methods and systems for sequencing 5? and/or 3? cfDNA overhangs to identify overhang length and sequence topology data are described herein. The method can comprise, for example, the use of the cfDNA topology data to generate cfDNA overhang sequence libraries.Type: ApplicationFiled: December 15, 2023Publication date: January 8, 2026Applicants: Foundation Medicine, Inc., Roche Sequencing Solutions, Inc.Inventors: Cassandra BURKE, Benjamin MCNALLY, David PENKLER
-
Publication number: 20250382668Abstract: A method of detecting a lipid bilayer formed in a cell of a nanopore based sequencing chip is disclosed. An integrating capacitor is coupled with a lipid membrane, wherein the lipid membrane is between a working electrode and a counter electrode. An alternating current (AC) voltage is applied to the counter electrode. A voltage across the integrating capacitor is periodically sampled by an analog-to-digital converter (ADC). A change in the sampled voltage across the integrating capacitor in response to a change in the AC voltage is determined. Whether the lipid membrane comprises a lipid bilayer is detected based on the determined change in the sampled voltage across the integrating capacitor in response to the change in the AC voltage.Type: ApplicationFiled: June 24, 2025Publication date: December 18, 2025Applicant: Roche Sequencing Solutions, Inc.Inventors: Kevin Aliado, Roger J.A. Chen, Jing Luo, William Nielsen, Kyle Umeda, Ashraf Wahba